“Effects of the alpha synuclein aggregates could be greatly reduced by the anti-diabetic drug glibenclamide.”
Diabetic drug could slow the progression ... - Cure Parkinson's
Diabetic drug could slow the progression of Parkinson’s disease
"It is known that patients treated for type two diabetes have less prevalence of Parkinson’s disease."
Really ?
Yep.. theres lots of research on this. Here's one from last month: parkinsonsnewstoday.com/202...
Do you have type 2 diabetes?
hm, i wonder how accessible this drug is... and what it means to slow it down with it. interesting! thanks for sharing!
[cut-and-paste -- I drop this wherever it may be of interest ]
Bydureon, a repurposed Type 2 Diabetes drug is now in third-stage trials in UK for stopping Parkinson’s in its tracks — results expected 2023. Testing — mice, open label, double blind — has been going on for 10 years and it has been positive every time.
scienceofparkinsons.com/201...
According to a very sensitive test, Homeostasis Model Assessment for Insulin Resistance (HOMA-IR), 2/3 of Parkinson’s patients are supposed to be insulin resistant. IR may be treated with Bydureon (Exanatide). Just an angle that might get us one step closer to Bydureon.
Only 10 years, sounds like big pharm is involved. I would appreciate a trial now. forget the mice.